Here is What Hedge Funds Think About CEL-SCI Corporation (CVM)

In This Article:

Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities over the years (that's why their assets under management continue to swell). We believe hedge fund sentiment should serve as a crucial tool of an individual investor’s stock selection process, as it may offer great insights of how the brightest minds of the finance industry feel about specific stocks. After all, these people have access to smartest analysts and expensive data/information sources that individual investors can't match. So should one consider investing in CEL-SCI Corporation (NYSE:CVM)? The smart money sentiment can provide an answer to this question.

CEL-SCI Corporation (NYSE:CVM) investors should be aware of a decrease in activity from the world's largest hedge funds recently. CEL-SCI Corporation (NYSE:CVM) was in 5 hedge funds' portfolios at the end of March. The all time high for this statistic is 6. Our calculations also showed that CVM isn't among the 30 most popular stocks among hedge funds (click for Q1 rankings).

Today there are dozens of formulas investors employ to appraise stocks. A duo of the most innovative formulas are hedge fund and insider trading signals. Our experts have shown that, historically, those who follow the top picks of the best hedge fund managers can trounce the S&P 500 by a healthy amount (see the details here). Also, our monthly newsletter's portfolio of long stock picks returned 206.8% since March 2017 (through May 2021) and beat the S&P 500 Index by more than 115 percentage points. You can download a sample issue of this newsletter on our website .

Joseph Edelman of Perceptive Advisors
Joseph Edelman of Perceptive Advisors

Joseph Edelman of Perceptive Advisors

At Insider Monkey, we scour multiple sources to uncover the next great investment idea. For example, an activist hedge fund owns nearly 40% of this $23 biotech stock and is trying to buy the rest for around $50. So, we recommended a long position to our monthly premium newsletter subscribers. We go through lists like the 10 best battery stocks to pick the next Tesla that will deliver a 10x return. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. We read hedge fund investor letters and listen to stock pitches at hedge fund conferences. You can subscribe to our free daily newsletter on our homepage. With all of this in mind let's view the latest hedge fund action encompassing CEL-SCI Corporation (NYSE:CVM).